The specification and use of 18F-FES PET in breast cancer

The specification and use of 18F-FES PET in breast cancer

Estrogen receptor (ER) is overexpressed in approximately 2/3 of breast cancer patients’ lesions. Noninvasive detection of ER in vivo and dynamic monitoring of ER are crucial for individualized treatment decision-making. 16α-18F-17β-fluoroestradiol (18F-FES) positron emission tomography (PET) has bee...

Full description

Bibliographic Details
Main Author: YANG Zhongyi, XU Xiaoping, WANG Mingwei, ZHANG Yongping, YANG Jianwei, CHEN Yue, XU Wengui, LI Yaming, ZHANG Yingjian, SONG Shaoli
Format: Article
Language:English
Published: Editorial Office of China Oncology 2023-08-01
Series:Zhongguo aizheng zazhi
Subjects:
|breast cancer|positron emission tomography|16α-18f-17β-fluoroestradiol|specification|application
Online Access:http://www.china-oncology.com/fileup/1007-3639/PDF/1693553447922-717195834.pdf

Internet

http://www.china-oncology.com/fileup/1007-3639/PDF/1693553447922-717195834.pdf

Similar Items